Literature DB >> 18650363

Identification and characterization of two strains of human parechovirus 4 isolated from two clinical cases in Fukuoka City, Japan.

Kiyoko Wakatsuki1, Daisuke Kawamoto, Hiroshi Hiwaki, Kanako Watanabe, Hiromu Yoshida.   

Abstract

Reverse transcription-PCR targeting the VP0 gene of human parechoviruses (HPeVs) was used to identify two isolates from two Japanese children's stool specimens. Molecular analysis revealed that these isolates belonged to HPeV type 4, and their nucleotide identity in the P1 region was 85.0%.

Entities:  

Mesh:

Year:  2008        PMID: 18650363      PMCID: PMC2546714          DOI: 10.1128/JCM.00791-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Comparison of classic and molecular approaches for the identification of untypeable enteroviruses.

Authors:  M S Oberste; K Maher; M R Flemister; G Marchetti; D R Kilpatrick; M A Pallansch
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

2.  Arginine-glycine-aspartic acid motif is critical for human parechovirus 1 entry.

Authors:  Y Boonyakiat; P J Hughes; F Ghazi; G Stanway
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment.

Authors:  Sudhir Kumar; Koichiro Tamura; Masatoshi Nei
Journal:  Brief Bioinform       Date:  2004-06       Impact factor: 11.622

4.  Analysis of a new human parechovirus allows the definition of parechovirus types and the identification of RNA structural domains.

Authors:  Mohammed Al-Sunaidi; Cigdem H Williams; Pamela J Hughes; David P Schnurr; Glyn Stanway
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

5.  Characterization of echovirus 22 variants.

Authors:  D Schnurr; M Dondero; D Holland; J Connor
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

6.  Human parechovirus infections in Dutch children and the association between serotype and disease severity.

Authors:  K S M Benschop; J Schinkel; R P Minnaar; D Pajkrt; L Spanjerberg; H C Kraakman; B Berkhout; H L Zaaijer; M G H M Beld; K C Wolthers
Journal:  Clin Infect Dis       Date:  2005-12-12       Impact factor: 9.079

7.  Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination.

Authors:  K S Lole; R C Bollinger; R S Paranjape; D Gadkari; S S Kulkarni; N G Novak; R Ingersoll; H W Sheppard; S C Ray
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

8.  Isolation and identification of a novel human parechovirus.

Authors:  Miyabi Ito; Teruo Yamashita; Hideaki Tsuzuki; Naokazu Takeda; Kenji Sakae
Journal:  J Gen Virol       Date:  2004-02       Impact factor: 3.891

9.  Fourth human parechovirus serotype.

Authors:  Kimberley S M Benschop; Janke Schinkel; Manon E Luken; Peter J M van den Broek; Matthias F C Beersma; Negassi Menelik; Hetty W M van Eijk; Hans L Zaaijer; Christina M J E VandenBroucke-Grauls; Marcel G H M Beld; Katja C Wolthers
Journal:  Emerg Infect Dis       Date:  2006-10       Impact factor: 6.883

10.  Isolation and characterization of novel human parechovirus from clinical samples.

Authors:  Kanako Watanabe; Masayasu Oie; Masaya Higuchi; Makoto Nishikawa; Masahiro Fujii
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

View more
  3 in total

1.  Identification of potential recombination breakpoints in human parechoviruses.

Authors:  Jan Zoll; Jochem M D Galama; Frank J M van Kuppeveld
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

2.  Emergence of Parechovirus A4 Central Nervous System Infections among Infants in Kansas City, Missouri, USA.

Authors:  A Sasidharan; C J Harrison; D Banerjee; R Selvarangan
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

3.  Complete genome sequence of a novel type of human parechovirus strain reveals natural recombination events.

Authors:  Guangming Sun; Yong Wang; Gang Tao; Quan Shen; Weiping Cao; Xianlu Chang; Wen Zhang; Chen Shao; Miaoli Yi; Shihe Shao; Yan Yang
Journal:  J Virol       Date:  2012-08       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.